As part of Summit LA 2019, Peter Diamandis delivered the thought-provoking Leaps Talk ‘CRISPR, AI, & Brain-Machine Interface, the Future is Faster Than You Think’ at the historic Ace Theatre in downtown LA. Peter explores the potential of genetic engineering, AI, and other exponential technologies in curing ‘incurable’ diseases, transforming business models and what it means to be human. Co-Director of the Summit Institute, Ellen Gustafson, introduced the talk.
Peter Diamandis – Entrepreneur, Best-selling Author, Founder of Singularity University and XPRIZE
Peter Diamandis attended MIT where he earned degrees in molecular genetics and aerospace engineering before obtaining an M.D. from Harvard Medical School. He then went on to become an innovative entrepreneur, starting over 20 companies in the areas of longevity, space, venture capital and education.
About Leaps Talks: Breakthroughs in biotech could change the world for the better, but they also raise important ethical questions that cannot solely be answered by scientists and investors. That’s why we’re engaging society in this critical dialogue. Leaps Talks is a speaker series that aims to drive this dialogue by gathering leading minds from distinct disciplines to discuss ethics, opportunities, and challenges in biotech innovation. Learn more: https://leaps.bayer.com/engagement/
About us: Leaps by Bayer invests in paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better. Our approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity.
Connect with us:
Tweets by LeapsByBayer